drugset / Trial / NCT01410331
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blind, placebo controlled study designed to evaluate the safety and efficacy of JVS-100 given to adult subjects with critical limb ischemia (CLI).
Timeline
- Start
- 2012-03
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JVS-100 | Other / unclassified | 4 mg | Intramuscular |
| Subject | JVS-100 | Other / unclassified | 8 mg | Intramuscular |
| Subject | JVS-100 | Other / unclassified | 16 mg | Intramuscular |